Literature DB >> 8130708

An interview study of participants in the Tacoma, Washington, syringe exchange.

H Hagan1, D C Des Jarlais, D Purchase, S R Friedman, T Reid, T A Bell.   

Abstract

Although European and Australian studies of syringe exchange programs have reported safer injection among participants and no increase in drug use, the generalizability of these findings to the US is uncertain. We report on the operations and potential effectiveness of the longest-operating syringe exchange in the US and compare our results to studies of exchange programs outside the US. The sample of 204 study subjects reported no change in the frequency of injection, from 155 to 152 injections per month, and a decline in the frequency of unsafe injections, from 56 to 30 times per month, while participating in the program. In all studies, participants report reduction in unsafe injections, and no increase in illicit drug use. However, the comparison also suggests that a high proportion of Tacoma exchangers have higher initial rates of drug injection, unsafe injection and homelessness, all of which were associated with unsafe injection while using the exchange. These indicate a need for additional services but that the Tacoma program is no less effective than European and Australian programs.

Entities:  

Mesh:

Year:  1993        PMID: 8130708     DOI: 10.1111/j.1360-0443.1993.tb02044.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  11 in total

1.  Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs.

Authors:  H Hagan; J P McGough; H Thiede; S G Hopkins; N S Weiss; E R Alexander
Journal:  J Urban Health       Date:  2000-03       Impact factor: 3.671

2.  Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.

Authors:  H Hagan; H Thiede
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

3.  Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Authors:  Ryan J Deibert; Gary Goldbaum; Theodore R Parker; Holly Hagan; Robert Marks; Michael Hanrahan; Hanne Thiede
Journal:  Am J Public Health       Date:  2006-06-29       Impact factor: 9.308

4.  Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.

Authors:  Stephanie R Bialek; William A Bower; Karen Mottram; Dave Purchase; T Nakano; Omana Nainan; Ian T Williams; Beth P Bell
Journal:  J Urban Health       Date:  2005-07-27       Impact factor: 3.671

5.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors:  H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

Review 6.  Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.

Authors:  Antonio L Estrada
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

7.  The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use.

Authors:  D C Des Jarlais; P Friedmann; H Hagan; S R Friedman
Journal:  Am J Public Health       Date:  1996-12       Impact factor: 9.308

Review 8.  Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done.

Authors:  D C Des Jarlais; S R Friedman
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

9.  The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms.

Authors:  Christopher M Jones; Faraah Bekheet; Ju Nyeong Park; G Caleb Alexander
Journal:  Epidemiol Rev       Date:  2020-01-31       Impact factor: 4.280

10.  HIV Risk Among Urban and Suburban People Who Inject Drugs: Elevated Risk Among Fentanyl and Cocaine Injectors in Maryland.

Authors:  Ju Nyeong Park; Jill Owczarzak; Glenna Urquhart; Miles Morris; Noelle P Weicker; Saba Rouhani; Susan G Sherman
Journal:  AIDS Behav       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.